Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
5.
JAMA Ophthalmol ; 139(8): 896-897, 2021 08 01.
Article in English | MEDLINE | ID: covidwho-1290764

ABSTRACT

Importance: Emerging vision scientists who have yet to be awarded their first independent funding may have their research careers disproportionately affected by early COVID-19-related disruptions. In September 2020, the Alliance for Eye and Vision Research convened a panel of 22 such scientists (nominated by their academic institutions) to communicate to the US Congress about the importance of vision research. As part of the effort, interviews were conducted with scientists about the effect of the pandemic on their research. Observations: Qualitative areas of adverse consequences from the early months of COVID-19 disruptions included striking interruptions of patient-based research, limits on other types of clinical research, loss of research time for scientists with young children (especially women), challenges with animal colonies and cell cultures, impediments to research collaborations, and loss of training time. Conclusions and Relevance: The early months during the COVID-19 pandemic increased career stress on many early-stage investigators in the vision field and delayed (and may potentially derail) their ability to attract their first independent research funding grant. As a result, federal and private granting agencies may need to take these factors into account to retain talented, early-stage vision researchers.


Subject(s)
Biomedical Research/organization & administration , COVID-19/complications , Career Choice , Ophthalmology/organization & administration , Research Personnel/education , SARS-CoV-2 , Stress, Psychological/etiology , Biomedical Research/education , Child, Preschool , Female , Humans , Male , Ophthalmology/education , Quarantine/psychology , Research Personnel/psychology , Research Support as Topic/organization & administration , Stress, Psychological/psychology , Surveys and Questionnaires , United States
13.
Heart Lung Circ ; 29(11): 1588-1595, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-728566

ABSTRACT

BACKGROUND: Cardiovascular disease is the leading cause of death in Australia. Investment in research solutions has been demonstrated to yield health and a 9.8-fold return economic benefit. The sector, however, is severely challenged with success rates of traditional peer-reviewed funding in decline. Here, we aimed to understand the perceived challenges faced by the cardiovascular workforce in Australia prior to the COVID-19 pandemic. METHODS: We used an online survey distributed across Australian cardiovascular societies/councils, universities and research institutes over a period of 6 months during 2019, with 548 completed responses. Inclusion criteria included being an Australian resident or an Australian citizen who lived overseas, and a current or past student or employee in the field of cardiovascular research. RESULTS: The mean age of respondents was 42±13 years, 47% were male, 85% had a full-time position, and 40% were a group leader or laboratory head. Twenty-three per cent (23%) had permanent employment, and 82% of full-time workers regularly worked >40 hours/week. Sixty-eight per cent (68%) said they had previously considered leaving the cardiovascular research sector. If their position could not be funded in the next few years, a staggering 91% of respondents would leave the sector. Compared to PhD- and age-matched men, women were less likely to be a laboratory head and to feel they had a long-term career path as a cardiovascular researcher, while more women were unsure about future employment and had considered leaving the sector (all p<0.05). Greater job security (76%) and government and philanthropic investment in cardiovascular research (72%) were highlighted by responders as the main changes to current practices that would encourage them to stay. CONCLUSION: Strategic solutions, such as diversification of career pathways and funding sources, and moving from a competitive to a collaborative culture, need to be a priority to decrease reliance on government funding and allow cardiovascular researchers to thrive.


Subject(s)
Biomedical Research , Cardiovascular Diseases , Coronavirus Infections/epidemiology , Financial Management , Pneumonia, Viral/epidemiology , Research Personnel , Research Support as Topic , Workforce , Adult , Australia , Betacoronavirus , Biomedical Research/economics , Biomedical Research/organization & administration , Biomedical Research/trends , COVID-19 , Employment/economics , Employment/psychology , Female , Financial Management/methods , Financial Management/organization & administration , Financial Management/statistics & numerical data , Financing, Government , Humans , Male , Organizational Culture , Pandemics , Planning Techniques , Research Personnel/economics , Research Personnel/psychology , Research Personnel/statistics & numerical data , Research Support as Topic/organization & administration , Research Support as Topic/trends , SARS-CoV-2 , Surveys and Questionnaires , Workforce/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL